T he m em bers of the Editorial Board and I w elcom e you to the ® rst issue of Sarcom a. T his is a specialist journal that I hope will m eet the needs of all w ho are interested in this group of diseases. T he aim of this journal is to provide a focus and forum for all involved in sarcoma research. T his includes scientists and clinicians and stretches from molecular biology through pathology, radiology, surgery, radiotherapy, m edical oncology, paediatric oncology to epidemiology. W e w elcom e original articles, review s, case reports and letters, and we w ould be pleased to publish abstracts from m eetings held to encourage multidisciplinary research.
The publication of Sarcom a coincides with the ® rst steps towards truly international collaboration in this ® eld. Professor Suit and his colleagues on both sides of the Atlantic have set up the Connective T issue O ncology Society, whose aim s are also to encourage international collaboration and the exchange of ideas and data. That is the only w ay in which to m ake progress in this heterogeneous group of diseases. W ithout cooperation the im portant questions such as the role of adjuvant chem otherapy in high-grade sarcom a cannot be answ ered. Progress in the m anagem ent of sarcom as depends on relevant high-quality science being available to all interested workers: Sarcom a is here to provide a reliable focus for this w ork.
Som e 1500 relevant articles are published each year. W e would like to encourage you to consider subm itting yours to Sarcom a. W e hope that you w ill enjoy its content and, by working together with us, drive forw ard im provem ents in the diagnosis and m anagem ent of this diverse group of diseases.
Lastly, I would like to thank all m embers of the Editorial Board who have helped m e with turning the idea of a dedicated journal into reality. 
